Table 4 Plasma lipid concentrations in the combined hyperlipidemia subjects, grouped by LPL genotype.
From: The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion
| Â | Â | SS (n = 199) | SX + XX (n = 13) | p-value |
|---|---|---|---|---|
Age |  | 53.3 ± 12.28 (198) | 51.7 ± 8.70 (13) | 0.647 |
BMI |  | 27.6 ± 4.60 (145) | 29.6 ± 3.21 (9) | 0.216 |
TG* | Total | 383.8 ± 357.69 (199) | 267.2 ± 65.24 (13) | 0.099 |
|  | VLDL | 281.7 ± 262.98 (199) | 184.6 ± 62.40 (13) | 0.060 |
|  | LDL | 76.3 ± 183.55 (199) | 59.4 ± 24.22 (13) | 0.809 |
|  | HDL | 21.7 ± 8.72 (199) | 21.9 ± 19.84 (13) | 0.075 |
C* | Total | 295.5 ± 73.96 (199) | 269.2 ± 48.10 (13) | 0.264 |
|  | VLDL | 70.4 ± 59.29 (199) | 48.4 ± 21.43 (13) | 0.045 |
|  | LDL | 180.8 ± 56.74 (199) | 175.3 ± 43.55 (13) | 0.926 |
|  | HDL | 40.4 ± 11.87 (199) | 43.7 ± 20.09 (13) | 0.661 |
TG/HDLC | 11.70 ± 18.07 (199) | 7.82 ± 5.849 (13) | 0.153 | |